marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Pacira BioSciences Financial Ratios 2011-2024 | PCRX
Annual Financial Ratios Pacira BioSciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
33.0 | 122.6 | 66.2 | 19.4 | -162.1 | -3543.9 | -34.1 | -35.8 | 1169.8 | -276.3 | -34.4 | -11.3 | -4.1 |
P/S |
2.1 | 2.9 | 5.1 | 6.6 | 4.2 | 4.9 | 5.1 | 4.9 | 8.7 | 19.2 | 25.7 | 15.2 | 11.3 |
EPS |
0.9 | 0.3 | 0.9 | 3.4 | -0.3 | -0.0 | -1.1 | -1.0 | 0.1 | -0.4 | -1.9 | -1.7 | -2.6 |
EV (Enterprise Value) |
1.93 B | 2.75 B | 3.54 B | 3.37 B | 2.18 B | 1.9 B | 1.75 B | 1.49 B | 2.29 B | 3.91 B | 2.31 B | 629 M | 197 M |
EBITDA per Share |
3.53 | 3.33 | 2.68 | 1.55 | 0.998 | 0.749 | -0.157 | -0.513 | 0.573 | 0.138 | -1.43 | -1.44 | -1.77 |
EV/EBITDA |
29.6 | 62.9 | 48.6 | 59.6 | -268.3 | -74.9 | 106.1 | 791.6 | -48.1 | -13.9 | -5.4 | ||
PEG |
0.86 | -1.56 | -0.68 | -0.13 | 0.06 | -35.77 | 6.95 | 0.02 | 10.37 | -3.46 | 2.82 | -0.33 | -0.04 |
P/B |
1.6 | 2.5 | 3.8 | 4.6 | 5.0 | 5.2 | 5.2 | 6.2 | 9.9 | 22.1 | 53.3 | 9.0 | 3.7 |
P/CF |
8.9 | 13.4 | 22.1 | 36.6 | 29.6 | 48.6 | -979.7 | 155.2 | -176.9 | 1058.5 | -39.2 | -6.7 | -4.8 |
ROE % |
4.82 | 2.05 | 5.75 | 23.48 | -3.10 | -0.15 | -15.25 | -17.33 | 0.85 | -8.01 | -154.93 | -79.39 | -89.76 |
ROA % |
2.66 | 0.95 | 2.02 | 11.42 | -1.33 | -0.07 | -6.78 | -9.69 | 0.48 | -4.21 | -37.63 | -46.66 | -38.18 |
ROCE % |
10.08 | 7.74 | 12.31 | 7.48 | 4.94 | 2.78 | -3.51 | -9.24 | 3.97 | -2.78 | -111.30 | -50.36 | -44.23 |
Current Ratio |
2.2 | 1.9 | 1.5 | 1.9 | 3.8 | 7.9 | 7.0 | 5.4 | 1.7 | 1.5 | 0.9 | 4.3 | 2.6 |
DSO |
55.1 | 53.3 | 50.3 | 42.7 | 41.2 | 41.1 | 40.3 | 39.5 | 37.9 | 41.3 | 62.2 | 40.6 | 49.2 |
DIO |
198.1 | 178.2 | 212.4 | 191.2 | 199.4 | 204.1 | 171.9 | 103.7 | 313.2 | 137.9 | 103.7 | 137.2 | 27.1 |
DPO |
30.6 | 23.6 | 27.3 | 36.1 | 43.8 | 60.4 | 60.9 | 24.9 | 44.4 | 31.9 | 20.5 | 29.2 | 75.0 |
Operating Cycle |
253.2 | 231.5 | 262.7 | 234.0 | 240.6 | 245.3 | 212.2 | 143.2 | 351.1 | 179.2 | 165.9 | 177.8 | 76.3 |
Cash Conversion Cycle |
222.7 | 207.9 | 235.4 | 197.8 | 196.8 | 184.9 | 151.4 | 118.3 | 306.7 | 147.4 | 145.5 | 148.6 | 1.3 |
All numbers in USD currency
Quarterly Financial Ratios Pacira BioSciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-3.11 | 0.41 | 0.19 | - | 0.23 | 0.56 | -0.43 | - | -0.02 | 0.44 | 0.15 | - | 0.4 | 0.43 | 0.24 | 0.33 | 3.03 | -0.17 | 0.19 | -0.12 | -0.15 | 0.07 | -0.07 | 0.2 | -0.02 | 0.06 | -0.26 | 0.11 | -0.19 | -0.49 | -0.52 | -0.11 | -0.59 | -0.21 | -0.1 | -0.07 | 0.08 | 0.03 | 0.03 | -0.39 | -0.08 | -0.14 | -0.34 | -0.36 | -0.44 | -0.42 | -0.71 | -0.5 | -0.49 | -0.27 | -0.47 | - | -0.55 | -0.51 | -0.98 |
EBITDA per Share |
-2.89 | 0.71 | 0.68 | - | 0.47 | 0.97 | 0.36 | - | 0.59 | 0.83 | 0.83 | - | 1.05 | 0.85 | 0.55 | - | 0.76 | 0.06 | 0.52 | - | 0.41 | 0.34 | 0.11 | - | 0.32 | 0.3 | -0.1 | - | 0.16 | -0.22 | -0.29 | - | -0.3 | - | 0.02 | - | 0.37 | 0.2 | 0.17 | 0.14 | 0.18 | 0.06 | -0.2 | - | -0.26 | -0.28 | -0.53 | - | -0.35 | -0.21 | -0.38 | - | -0.48 | -0.47 | -0.61 |
ROE % |
-14.68 | 5.77 | 6.81 | 1.95 | 1.86 | 0.47 | -0.10 | 3.50 | 5.96 | 8.50 | 8.65 | 6.83 | 9.17 | 27.71 | 23.76 | 23.48 | 19.76 | -2.95 | -1.01 | -3.10 | 0.85 | 2.37 | 2.40 | -0.15 | -1.08 | -3.60 | -11.46 | -15.25 | -18.70 | -26.11 | -22.68 | -17.33 | -16.66 | -5.12 | -1.49 | 0.85 | -6.02 | -9.19 | -12.14 | -19.42 | -40.39 | -74.47 | -105.55 | -154.93 | -150.77 | -138.84 | -117.42 | -79.39 | -74.26 | -70.05 | -75.61 | -58.10 | -19.70 | -18.15 | -20.25 |
ROA % |
-7.01 | 3.13 | 3.65 | 1.10 | 1.06 | 0.31 | -1.00 | 0.68 | 1.98 | 2.97 | 4.40 | 3.55 | 4.69 | 13.59 | 11.58 | 11.42 | 9.69 | -1.25 | -0.35 | -1.33 | 0.46 | 1.10 | 1.15 | -0.07 | -0.54 | -1.66 | -5.17 | -6.78 | -8.53 | -12.98 | -11.87 | -9.69 | -9.32 | -2.87 | -0.83 | 0.48 | -3.08 | -4.80 | -6.35 | -10.19 | -13.03 | -20.81 | -27.53 | -37.63 | -45.18 | -50.53 | -49.67 | -46.66 | -40.45 | -34.77 | -35.09 | -24.71 | -8.38 | -7.72 | -8.61 |
ROCE % |
-11.79 | 8.95 | 10.68 | 6.66 | 9.43 | 10.06 | 9.25 | 9.34 | 13.72 | 15.33 | 16.27 | 12.43 | 15.27 | 13.74 | 7.52 | 4.45 | 5.13 | 2.96 | 5.60 | 2.47 | 3.73 | 4.31 | 4.86 | 1.14 | -0.14 | -2.68 | -10.36 | -11.95 | -21.48 | -29.73 | -27.03 | -13.50 | -11.16 | 0.71 | 4.48 | 4.70 | 1.68 | -1.23 | -3.72 | -10.66 | -38.71 | -69.20 | -96.66 | -105.38 | -129.23 | -122.02 | -102.96 | -50.82 | -68.91 | -63.16 | -70.77 | -50.52 | -18.09 | -17.67 | -14.75 |
Current Ratio |
2.0 | 2.1 | 2.3 | 2.2 | 2.2 | 2.1 | 2.0 | 1.9 | 1.8 | - | 1.6 | 1.5 | 2.1 | 2.1 | 2.0 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.1 | 2.1 | 2.1 | 2.1 | 1.3 | 1.3 | 1.3 | 1.3 | 2.4 | 2.4 | 2.4 | 2.4 | 1.7 | 1.7 | 1.7 | 1.7 |
DSO |
55.6 | 52.9 | 56.6 | - | 54.6 | 51.8 | 54.5 | - | 25.5 | 24.8 | 54.4 | - | 42.3 | 40.7 | 40.5 | 37.0 | 41.2 | 64.1 | 43.4 | 35.4 | 41.4 | 42.3 | 42.7 | 36.5 | 41.5 | 41.2 | 42.6 | 36.5 | 42.9 | 40.7 | 40.6 | 37.5 | 40.0 | 39.2 | 38.9 | 34.0 | 37.9 | 39.9 | 37.7 | 10.3 | 39.2 | 43.3 | 46.0 | 39.7 | 57.2 | 77.7 | 74.6 | 38.0 | 46.8 | 32.2 | 37.8 | - | 48.7 | 53.0 | - |
DIO |
252.8 | 206.4 | 193.5 | - | 216.5 | 175.2 | 175.9 | - | 87.2 | 93.4 | 255.8 | - | 174.4 | 168.1 | 188.1 | 167.1 | 196.7 | 264.5 | 188.7 | 166.7 | 238.5 | 211.1 | 178.6 | 184.8 | 232.5 | 211.9 | 179.4 | 177.4 | 207.3 | 158.7 | 134.9 | 120.8 | 66.1 | 123.8 | 209.1 | 289.6 | 353.8 | 297.2 | 235.9 | 34.5 | 130.9 | 133.8 | 112.8 | 77.2 | 96.0 | 139.0 | 110.7 | 113.9 | 118.7 | 164.8 | 93.6 | - | 33.8 | 36.5 | - |
DPO |
44.7 | 28.6 | 23.8 | - | 46.7 | 39.2 | 30.2 | - | 11.6 | 13.4 | 32.1 | - | 26.4 | 27.6 | 28.4 | 27.0 | 31.7 | 42.7 | 35.6 | 36.6 | 52.4 | 46.3 | 45.4 | 54.7 | 68.8 | 62.7 | 57.9 | 62.8 | 73.4 | 56.2 | 41.1 | 29.0 | 15.9 | 29.7 | 36.6 | 41.0 | 50.1 | 42.1 | 40.2 | 8.0 | 30.2 | 30.9 | 24.7 | 15.2 | 18.9 | 27.4 | 22.6 | 24.2 | 25.2 | 35.1 | 42.2 | - | 93.5 | 100.8 | - |
Operating Cycle |
308.4 | 259.3 | 250.1 | - | 271.1 | 227.0 | 230.5 | - | 112.6 | 118.2 | 310.2 | - | 216.7 | 208.8 | 228.6 | 204.1 | 237.9 | 328.6 | 232.1 | 202.2 | 279.9 | 253.3 | 221.3 | 221.3 | 274.0 | 253.1 | 222.0 | 214.0 | 250.2 | 199.4 | 175.5 | 158.3 | 106.1 | 163.0 | 247.9 | 323.6 | 391.7 | 337.1 | 273.7 | 44.8 | 170.2 | 177.1 | 158.8 | 116.9 | 153.2 | 216.7 | 185.3 | 151.9 | 165.5 | 197.0 | 131.4 | - | 82.6 | 89.5 | - |
Cash Conversion Cycle |
263.6 | 230.7 | 226.4 | - | 224.4 | 187.7 | 200.2 | - | 101.0 | 104.8 | 278.1 | - | 190.3 | 181.2 | 200.2 | 177.1 | 206.2 | 285.9 | 196.4 | 165.6 | 227.6 | 207.0 | 175.9 | 166.6 | 205.2 | 190.4 | 164.1 | 151.2 | 176.8 | 143.3 | 134.3 | 129.3 | 90.2 | 133.3 | 211.4 | 282.5 | 341.5 | 294.9 | 233.4 | 36.8 | 139.9 | 146.2 | 134.1 | 101.7 | 134.3 | 189.2 | 162.7 | 127.7 | 140.2 | 161.9 | 89.2 | - | -10.9 | -11.3 | - |
All numbers in USD currency